Bristol-Myers Squibb Company (BMY)

Net profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	8,025,000	6,327,000	6,994,000	-9,015,000	3,439,000
Revenue	US$ in thousands	45,006,000	46,159,000	46,385,000	42,518,000	26,145,000
Net profit margin		17.83%	13.71%	15.08%	-21.20%	13.15%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $8,025,000K ÷ $45,006,000K
= 17.83%

The net profit margin of Bristol-Myers Squibb Co. has shown variability over the past five years. In 2023, the net profit margin improved to 17.83% from 13.71% in 2022, indicating that the company effectively translated revenues into profit. This suggests strong cost management and operational efficiency. The net profit margin was also relatively healthy in 2021 at 15.08%.

However, in 2020, the company faced challenges as indicated by a negative net profit margin of -21.20%. This suggests that expenses exceeded revenues during that period, leading to a loss. Despite this setback, Bristol-Myers Squibb Co. managed to bounce back in 2019 with a net profit margin of 13.15%.

Overall, the positive trend observed in recent years, culminating in a notable increase in 2023, is a positive sign for the company's profitability and financial performance. Monitoring the net profit margin is crucial for evaluating the company's ability to generate profit from its operations and manage costs effectively.